Breaking News, Collaborations & Alliances

DSM in Supply Agreement with QRxPharma

To make MoxDuo capsules through 2015

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

DSM Pharmaceutical Products has signed a manufacturing and supply agreement with QRxPharma for the U.S. production of its novel MoxDuo pain management capsules through 2015. Financial terms were not disclosed. The agreement covers the production of MoxDuo Capsules, an immediate-release Dual Opioid pain therapy, a patented 3:2 fixed ratio combination of morphine and oxycodone. DSM will supply commercial volumes upon marketing approval. DSM operates a 1.5 million-sq.-ft. finished dosage facility ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters